![HDL mimetic CER-001 targets atherosclerotic plaques in patients Kang He Zheng, Fleur M. van der Valk, Loek P. Smits, Mara Sandberg, Jean-Louis Dasseux, - ppt download HDL mimetic CER-001 targets atherosclerotic plaques in patients Kang He Zheng, Fleur M. van der Valk, Loek P. Smits, Mara Sandberg, Jean-Louis Dasseux, - ppt download](https://images.slideplayer.com/37/10747081/slides/slide_2.jpg)
HDL mimetic CER-001 targets atherosclerotic plaques in patients Kang He Zheng, Fleur M. van der Valk, Loek P. Smits, Mara Sandberg, Jean-Louis Dasseux, - ppt download
![PDF) Erratum to “α-Cycloalkyl-substituted ω-keto-dicarboxylic acids as lipid regulating agents” | Jean-Louis Dasseux - Academia.edu PDF) Erratum to “α-Cycloalkyl-substituted ω-keto-dicarboxylic acids as lipid regulating agents” | Jean-Louis Dasseux - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/51458516/mini_magick20190125-16118-ur8q4r.png?1548437452)
PDF) Erratum to “α-Cycloalkyl-substituted ω-keto-dicarboxylic acids as lipid regulating agents” | Jean-Louis Dasseux - Academia.edu
![Le Club Éco. Jean-Louis Dasseux, Cerenis Therapeutics : "Un marché potentiel de 35 milliards de dollars" Le Club Éco. Jean-Louis Dasseux, Cerenis Therapeutics : "Un marché potentiel de 35 milliards de dollars"](https://static.latribune.fr/384939/image.jpg)
Le Club Éco. Jean-Louis Dasseux, Cerenis Therapeutics : "Un marché potentiel de 35 milliards de dollars"
![Cerenis Therapeutics, des thérapies pour lutter contre les maladies cardio-vasculaires - ladepeche.fr Cerenis Therapeutics, des thérapies pour lutter contre les maladies cardio-vasculaires - ladepeche.fr](https://images.ladepeche.fr/api/v1/images/view/5c3470173e45464a654b083f/full/image.jpg)
Cerenis Therapeutics, des thérapies pour lutter contre les maladies cardio-vasculaires - ladepeche.fr
Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA[S
![Andrew MCKEE | Indiana University Bloomington, Indiana | IUB | Department of Chemistry | Research profile Andrew MCKEE | Indiana University Bloomington, Indiana | IUB | Department of Chemistry | Research profile](https://i1.rgstatic.net/ii/profile.image/11431281081337564-1661710217991_Q512/Andrew-Mckee-6.jpg)
Andrew MCKEE | Indiana University Bloomington, Indiana | IUB | Department of Chemistry | Research profile
CER-001: Analysis of clinical results to be presented at the American Heart Association Scientific Congress, on November 9, 201
Long Hydrocarbon Chain Keto Diols and Diacids that Favorably Alter Lipid Disorders in Vivo | Journal of Medicinal Chemistry
![PDF) No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels PDF) No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels](https://i1.rgstatic.net/publication/343972501_No_benefit_of_HDL_mimetic_CER-001_on_carotid_atherosclerosis_in_patients_with_genetically_determined_very_low_HDL_levels/links/603caa884585158939d99581/largepreview.png)